| Prev Close | 89.62 |
| Day Low/High | 88.50 / 90.44 |
| 52 Wk Low/High | 78.95 / 116.49 |
| Avg Volume | 1.32M |
Quest Diagnostics Inc. (DGX)
89.24
NYSE : Health Services
| Exchange | NYSE |
| Shares Outstanding | 134.26M |
| Market Cap | 12.03B |
| EPS | 5.40 |
| P/E Ratio | 16.94 |
| Div & Yield | 2.12 (2.29%) |
Latest News
Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either
For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.
The Really Big Money Rushes to Super Bowl
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Quest Diagnostics Investigates Third-Party Data Breach
Shares of Quest Diagnostics were slightly higher Tuesday after announcing an investigation into a data breach by a third-party that affected the health records of 34,000 people.
Exxon Mobil CEO is Trump's Choice for Secretary of State
The 64 year old Tillerson became CEO of the Texas based oil giant in 2004 and has a close business relationship with Russian President Vladimir Putin.
Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare
Quest Diagnostics CEO Stephen Rusckowski discusses the Affordable Care Act and what's next for his company.
Bullish and Bearish Reversals for the Week
Here's a window into what institutional investors may be doing and how to profit from that.
Cramer: These Stocks Are the Key to the Bull Market
Let me give you the unassailable themes.
Laboratory Corp. of America Looks Pretty Healthy
LH's $5.7B Covance takeover could be just what the doctor ordered.
Quest Diagnostics Is on a Mission to Rally
Charts show DGX should break out above resistance soon.
Theranos Must Refute Claims Specifically
Questions will continue to swirl until facts emerge.
Quest Diagnostics Can't Stop the Bleeding; 10% Slide in Sight
Quest could be vulnerable to a deep correction, but a decline to next support around $60 seems like the path of least resistance.
Jim Cramer Says Blackberry Needs a Catalyst, TransUnion Will Be a Buy
Jim Cramer answers viewers’ Twitter (TWTR) questions from the floor of the New York Stock Exchange.
Playing Bio-Reference Labs With Options
Selling covered calls and naked puts can reduce risk. (Updated)
Market Wrap: Yellen Speech Can't Free Stocks From Narrow Range
Light volume precedes break for Memorial Day.
Today's Movers and Something to Watch
Major indices continue to show little movement as we approached the noon hour, although they have turned down in the last half hour. I can't recall such a flat week this year. Maybe everyone is already in the Hamptons and it is just the computers tr...
The 7 Pillars of Healthcare Strength
Here are healthcare stocks of all shares and sizes with strong charts.
Get Some Positive Lab Results
Try this options play for the sometimes volatile Bio-Reference Laboratories.
